Bristol-Myers Squibb's market cap is currently ―. The company's EPS TTM is $-3.1; its P/E ratio is -14.57; and it has a dividend yield of 5.17%. Bristol-Myers Squibb is scheduled to report earnings on July 26, 2024, and the estimated EPS forecast is $1.69. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 11.87B	$ 11.48B	$ 10.97B	$ 10.92B	$ 11.34B
Gross Profit	$ 8.93B	$ 8.73B	$ 8.46B	$ 10.77B	$ 6.44B
EBIT	$ -11.40B	$ 1.11B	$ 2.42B	$ 2.14B	$ 2.16B
EBITDA	$ -8.87B	$ 3.58B	$ 4.85B	$ 4.57B	$ 4.59B
Net Income Common Stockholders	$ -11.91B	$ 1.76B	$ 6.61B	$ 2.07B	$ 2.27B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 9.67B	$ 12.28B	$ 8.01B	$ 8.73B	$ 9.27B
Total Assets	$ 99.03B	$ 95.16B	$ 91.26B	$ 93.49B	$ 94.28B
Total Debt	$ 55.68B	$ 39.77B	$ 37.60B	$ 37.68B	$ 37.83B
Net Debt	$ 46.01B	$ 27.49B	$ 29.59B	$ 28.95B	$ 28.56B
Total Liabilities	$ 82.48B	$ 65.67B	$ 62.20B	$ 61.46B	$ 62.40B
Stockholders Equity	$ 16.49B	$ 29.43B	$ 29.00B	$ 31.97B	$ 31.82B
Cash Flow	-
Free Cash Flow	$ 2.55B	$ 3.92B	$ 4.41B	$ 1.63B	$ 2.69B
Operating Cash Flow	$ 2.83B	$ 4.25B	$ 4.75B	$ 1.89B	$ 2.97B
Investing Cash Flow	$ -19.62B	$ -1.35B	$ -410.00M	$ -329.00M	$ -210.00M
Financing Cash Flow	$ 14.64B	$ 967.00M	$ -5.16B	$ -2.17B	$ -3.05B

Currency in USD

Bristol-Myers Squibb Earnings and Revenue History

Income Statement >

Bristol-Myers Squibb Debt to Assets

Balance Sheet >

Bristol-Myers Squibb Cash Flow

Cash Flow >

Bristol-Myers Squibb Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing